Dosage Optimization for Letrozole Treatment in Clomiphene-Resistant Patients with Polycystic Ovary Syndrome: A Prospective Interventional Study

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">   Variable</td><td align="center">Letrozole groups Mean ± SD</td><td align="center">Letrozole total cycle</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">Follicular development (mm)</td><td align="center"><span style="width: 74.362503px;"><svg height="11.2875" id="M24" style="vertical-align:-0.3003pt" version="1.1" viewbox="0 0 74.362503 11.2875" width="74.362503" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x32"></use></g><g transform="matrix(.017,-0,0,-.017,8.222,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,16.381,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,20.257,10.862)"><use xlink:href="#x33"></use></g><g transform="matrix(.017,-0,0,-.017,32.19,10.862)"><use xlink:href="#xB1"></use></g><g transform="matrix(.017,-0,0,-.017,45.942,10.862)"><use xlink:href="#x31"></use></g><g transform="matrix(.017,-0,0,-.017,54.102,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,57.977,10.862)"><use xlink:href="#x38"></use></g><g transform="matrix(.017,-0,0,-.017,66.137,10.862)"><use xlink:href="#x39"></use></g>
</svg></span></td><td align="center">113</td></tr><tr><td align="left">Serum E2 one day of HCG (pg/mL)</td><td align="center"><span style="width: 70.487503px;"><svg height="11.2875" id="M25" style="vertical-align:-0.3003pt" version="1.1" viewbox="0 0 70.487503 11.2875" width="70.487503" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<g transform="matrix(.017,-0,0,-.017,.062,10.862)"><use xlink:href="#x31"></use></g><g transform="matrix(.017,-0,0,-.017,8.222,10.862)"><use xlink:href="#x32"></use></g><g transform="matrix(.017,-0,0,-.017,16.381,10.862)"><use xlink:href="#x30"></use></g><g transform="matrix(.017,-0,0,-.017,28.314,10.862)"><use xlink:href="#xB1"></use></g><g transform="matrix(.017,-0,0,-.017,42.066,10.862)"><use xlink:href="#x31"></use></g><g transform="matrix(.017,-0,0,-.017,50.226,10.862)"><path d="M153 550l-26 -186q79 31 111 31q90 0 141.5 -51t51.5 -119q0 -93 -89 -166q-85 -69 -173 -71q-32 0 -61.5 11.5t-41.5 23.5q-18 17 -17 34q2 16 22 33q14 9 26 -1q61 -50 124 -50q60 0 93 43.5t33 104.5q0 69 -41.5 110t-121.5 41q-53 0 -102 -20l38 305h286l6 -8
l-26 -65h-233z" id="x35"></path></g><g transform="matrix(.017,-0,0,-.017,58.385,10.862)"><use xlink:href="#x2E"></use></g><g transform="matrix(.017,-0,0,-.017,62.261,10.862)"><use xlink:href="#x35"></use></g>
</svg></span></td><td align="center">113</td></tr><tr><td align="left">Pregnancy/cycles</td><td align="center">27 (23.89%)</td><td align="center">113</td></tr><tr><td align="left">Pregnancy/total patients</td><td align="center">27 (61.36%)</td><td align="center">113</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Obstetrics and Gynecology International

tab4

Table 4

Table 4: Dosage Optimization for Letrozole Treatment in Clomiphene-Resistant Patients with Polycystic Ovary Syndrome: A Prospective Interventional Study 

Table 4 | Dosage Optimization for Letrozole Treatment in Clomiphene-Resistant Patients with Polycystic Ovary Syndrome: A Prospective Interventional Study 